Details for New Drug Application (NDA): 020369
✉ Email this page to a colleague
The generic ingredient in CILOXAN is ciprofloxacin hydrochloride. There are thirty-four drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the ciprofloxacin hydrochloride profile page.
Summary for 020369
Tradename: | CILOXAN |
Applicant: | Sandoz |
Ingredient: | ciprofloxacin hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 020369
Mechanism of Action | Cytochrome P450 1A2 Inhibitors |
Suppliers and Packaging for NDA: 020369
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CILOXAN | ciprofloxacin hydrochloride | OINTMENT;OPHTHALMIC | 020369 | NDA | Novartis Pharmaceuticals Corporation | 0078-0841 | 0078-0841-01 | 3.5 g in 1 TUBE (0078-0841-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;OPHTHALMIC | Strength | EQ 0.3% BASE | ||||
Approval Date: | Mar 30, 1998 | TE: | RLD: | Yes |
Expired US Patents for NDA 020369
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sandoz | CILOXAN | ciprofloxacin hydrochloride | OINTMENT;OPHTHALMIC | 020369-001 | Mar 30, 1998 | 4,670,444*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription